Summary

Global Transradial Access Market was valued at USD 2.34 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.18% over the forecast period 2024-2032. Transradial access refers to a minimally invasive technique for accessing the arterial system via the radial artery in the wrist, primarily used for cardiovascular procedures such as angiography and angioplasty. This approach offers advantages such as reduced bleeding risks, quicker patient recovery, and increased comfort compared to traditional femoral access. Its applications span diagnostic and interventional cardiology, enhancing procedural efficiency and patient outcomes.
The Global Transradial Access Market is driven by surge in the incidence of cardiovascular diseases and diabetes fuels the expansion of the transradial access market. These conditions often require diagnostic and therapeutic procedures, such as angioplasty and catheterization, which can be performed using transradial minimally invasive technique involving the radial artery in the wrist. This method is preferred for its lower complication rates, quicker recovery times, and enhanced patient comfort compared to traditional femoral access. Additionally, the increasing geriatric population and the rising prevalence of chronic diseases are expected to significantly bolster market growth during the forecast period. Furthermore, a strong emphasis on technological advancements in transradial access is projected to create lucrative opportunities for market. However, lack of skilled professionals is going to impede the overall demand for the market during the forecast period 2024-2032.
The key regions considered for the Global Transradial Access Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is expected to dominate the transradial access market, attributed to the presence of advanced healthcare infrastructure and favorable reimbursement policies. Furthermore, Asia Pacific are also anticipated to exhibit substantial growth due to the increasing healthcare expenditure and rising awareness regarding cardiovascular procedures.
Major market players included in this report are:
Smiths Medical, Inc.
Medtronic plc
Edward Lifesciences
Merit Medical Systems, Inc.
Boston Scientific Corporation
Nipro Corporation
AngioDynamics
Oscor
Becton, Dickinson and Company
Terumo Corporation

The detailed segments and sub-segment of the market are explained below:
By Product Type:
• Catheters
• Guidewires
• Sheaths & Sheath Introducers
• Accessories
By Application Type:
• Drug Administration
• Fluid & Nutrition Administration
• Blood Transfusion
• Diagnostics & Testing
By End-User Type:
• Hospitals
• Clinics and Ambulatory Care Centers
• Others
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
• Historical year – 2021
• Base year – 2022
• Forecast period – 2023 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Global Transradial Access Market Executive Summary
1.1. Global Transradial Access Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Application Type
1.3.3. By End-User Type
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Transradial Access Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Transradial Access Market Dynamics
3.1. Market Drivers
3.1.1. Rise in Incidence of Cardiovascular Diseases and Diabetes
3.1.2. Expanding Geriatric Population
3.2. Market Challenges
3.2.1. Lack of Skilled Professionals
3.3. Market Opportunities
3.3.1. Technological Advancements in Transradial Access
3.3.2. Growth in Emerging Markets

Chapter 4. Global Transradial Access Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Transradial Access Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Transradial Access Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Catheters
5.2.2. Guidewires
5.2.3. Sheaths & Sheath Introducers
5.2.4. Accessories

Chapter 6. Global Transradial Access Market Size & Forecasts by Application Type 2022-2032
6.1. Segment Dashboard
6.2. Global Transradial Access Market: Application Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Drug Administration
6.2.2. Fluid & Nutrition Administration
6.2.3. Blood Transfusion
6.2.4. Diagnostics & Testing

Chapter 7. Global Transradial Access Market Size & Forecasts by End-User Type 2022-2032
7.1. Segment Dashboard
7.2. Global Transradial Access Market: End-User Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Clinics and Ambulatory Care Centers
7.2.3. Others

Chapter 8. Global Transradial Access Market Size & Forecasts by Region 2022-2032
8.1. North America Transradial Access Market
8.1.1. U.S. Transradial Access Market
8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
8.1.1.2. Application Type breakdown size & forecasts, 2022-2032
8.1.1.3. End-User Type breakdown size & forecasts, 2022-2032
8.1.2. Canada Transradial Access Market
8.1.2.1. Product Type breakdown size & forecasts, 2022-2032
8.1.2.2. Application Type breakdown size & forecasts, 2022-2032
8.1.2.3. End-User Type breakdown size & forecasts, 2022-2032
8.2. Europe Transradial Access Market
8.2.1. U.K. Transradial Access Market
8.2.2. Germany Transradial Access Market
8.2.3. France Transradial Access Market
8.2.4. Spain Transradial Access Market
8.2.5. Italy Transradial Access Market
8.2.6. Rest of Europe Transradial Access Market
8.3. Asia-Pacific Transradial Access Market
8.3.1. China Transradial Access Market
8.3.2. India Transradial Access Market
8.3.3. Japan Transradial Access Market
8.3.4. Australia Transradial Access Market
8.3.5. South Korea Transradial Access Market
8.3.6. Rest of Asia Pacific Transradial Access Market
8.4. Latin America Transradial Access Market
8.4.1. Brazil Transradial Access Market
8.4.2. Mexico Transradial Access Market
8.4.3. Rest of Latin America Transradial Access Market
8.5. Middle East & Africa Transradial Access Market
8.5.1. Saudi Arabia Transradial Access Market
8.5.2. South Africa Transradial Access Market
8.5.3. Rest of Middle East & Africa Transradial Access Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Smiths Medical, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Medtronic plc
9.3.3. Edward Lifesciences
9.3.4. Merit Medical Systems, Inc.
9.3.5. Boston Scientific Corporation
9.3.6. Nipro Corporation
9.3.7. AngioDynamics
9.3.8. Oscor
9.3.9. Becton, Dickinson and Company
9.3.10. Terumo Corporation

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes